We investigated the long‐term effects of PBO performed before age 50 years on amyloid beta (Aβ), tau, and neurodegeneration imaging biomarkers of Alzheimer's disease (AD). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.